These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 11248742

  • 1. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
    Zhou X, Loke KY, Pillai CC, How HK, Yap HK, Lee KO.
    Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
    [Abstract] [Full Text] [Related]

  • 2. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H, Hilding A, Ekström C, Barle H, Nyberg B, Möller C, Delhanty PJ, Baxter RC, Angelin B, Ekström TJ, Tally M.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children.
    Haffner D, Tönshoff B, Blum WF, Vickers M, Siebler T, Cronin MJ, Baxter RC, Mehls O.
    Kidney Int; 1997 Sep; 52(3):802-10. PubMed ID: 9291202
    [Abstract] [Full Text] [Related]

  • 4. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 5. Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects.
    Rasmussen MH, Juul A, Kjems LL, Hilsted J.
    Eur J Endocrinol; 2006 Oct; 155(4):575-81. PubMed ID: 16990657
    [Abstract] [Full Text] [Related]

  • 6. Plasma insulin-like growth factors (IGFs), IGF-Binding proteins (IGFBPs), acid-labile subunit (ALS) and IGFBP-3 proteolysis in individuals with clinical characteristics of Sotos syndrome.
    de Boer L, Hoogerbrugge CM, van Doorn J, van Buul-Offers SC, Karperien M, Wit JM.
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):615-27. PubMed ID: 15198293
    [Abstract] [Full Text] [Related]

  • 7. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF, Segovia B, Lassarre C, Binoux M, Gourmelen M.
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [Abstract] [Full Text] [Related]

  • 8. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF, Hall K, Ranke MB, Wilton P.
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
    [Abstract] [Full Text] [Related]

  • 10. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts.
    Adiyaman P, Ocal G, Berberoğlu M, Evliyaoğlu O, Aycan Z, Cetinkaya E, Bulca Y, Ersöz G, Akar N.
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):895-903. PubMed ID: 15270408
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y.
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [Abstract] [Full Text] [Related]

  • 12. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH, Moreland E, Rosenfeld RG, Gargosky SE.
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [Abstract] [Full Text] [Related]

  • 13. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM, Mendel P, Holly JM, Timmins AG, Camacho-Hübner C, Hughes SC, Ross RM, Blum WF, Langford RM.
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [Abstract] [Full Text] [Related]

  • 14. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG, Ropelato MG, Domené HM, Pennisi P, Heinrich JJ, Jasper HG.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic interest of acid-labile subunit measurement in relationship to other components of the IGF system in pediatric patients with growth or eating disorders.
    Barrios V, Argente J, Muñoz MT, Pozo J, Chowen JA, Hernández M.
    Eur J Endocrinol; 2001 Mar; 144(3):245-50. PubMed ID: 11248743
    [Abstract] [Full Text] [Related]

  • 16. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 17. Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.
    Tönshoff B, Blum WF, Mehls O.
    Pediatr Nephrol; 1996 Jun; 10(3):269-74. PubMed ID: 8792388
    [Abstract] [Full Text] [Related]

  • 18. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE, Nanto-Salonen K, Tapanainen P, Rosenfeld RG.
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [Abstract] [Full Text] [Related]

  • 19. No influence of prednisolone on IGFBP-3 proteolysis in healthy young men.
    Dall R, Wolthers T, Flyvbjerg A, Grøfte T, Sandahl Christiansen J, Jørgensen JO.
    Horm Res; 2001 Mar; 55(2):95-101. PubMed ID: 11509866
    [Abstract] [Full Text] [Related]

  • 20. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C, Woods KA, Miraki-Moud F, Hindmarsh PC, Clark AJ, Hansson Y, Johnston A, Baxter RC, Savage MO.
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.